Susanne Breitner1, Nadine Steckling-Muschack, Iana Markevych, Tianyu Zhao, Hanna Mertes, Dennis Nowak, Joachim Heinrich. 1. Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians Universityof Munich (LMU), Munich, GermanyInstitute of Epidemiology, Helmholtz Zentrum München GmbH - German Research Center for EnvironmentalHealth, Neuherberg, GermanyInstitute and Outpatient Clinic for Occupational, Social and Environmental Medicine, LMU Hospital,Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), Munich,GermanyInstitute of Psychology, Jagiellonian University, Krakow, Poland.
Abstract
BACKGROUND: The chronic effects of ozone have only rarely been investigated in disease burden studies to date. Our goal was to determine this disease burden in Germany over the period 2007-2016, with particular attention to estimation based on effect estimates adjusted for particulate matter (PM2.5) and nitrogen dioxide (NO2). METHODS: The nationwide, high-spatial-resolution (2 km × 2 km), population-based exposure to ozone in the summer months ("summer ozone") was calculated on the basis of modeled ozone data and population counts in Germany. Next, risk estimates derived from cohort studies were used to quantify the burden of chronic obstructive pulmonary disease (COPD). Data on population counts, life expectancy, and mortality in Germany were used to reflect the situation across the country as accurately as possible. RESULTS: The estimates of years of life lost (YLL) due to summer ozone ranged from 18.33 per 100 000 people (95% confidence interval [14.02; 22.08]) in 2007 to 35.77 per 100 000 people [27.45; 42.98] in 2015. These findings indicate that ozone affects the COPD burden independently of other harmful components of the air. No clear secular trend in the COPD burden can be seen over the period 2007 to 2016. CONCLUSION: Long-term exposure to ozone contributes to the COPD burden among the general population in Germany. As climate change may lead to a rise in the ozone concentration, more intensive research is required on the effects of ozone on health.
BACKGROUND: The chronic effects of ozone have only rarely been investigated in disease burden studies to date. Our goal was to determine this disease burden in Germany over the period 2007-2016, with particular attention to estimation based on effect estimates adjusted for particulate matter (PM2.5) and nitrogen dioxide (NO2). METHODS: The nationwide, high-spatial-resolution (2 km × 2 km), population-based exposure to ozone in the summer months ("summer ozone") was calculated on the basis of modeled ozone data and population counts in Germany. Next, risk estimates derived from cohort studies were used to quantify the burden of chronic obstructive pulmonary disease (COPD). Data on population counts, life expectancy, and mortality in Germany were used to reflect the situation across the country as accurately as possible. RESULTS: The estimates of years of life lost (YLL) due to summer ozone ranged from 18.33 per 100 000 people (95% confidence interval [14.02; 22.08]) in 2007 to 35.77 per 100 000 people [27.45; 42.98] in 2015. These findings indicate that ozone affects the COPD burden independently of other harmful components of the air. No clear secular trend in the COPD burden can be seen over the period 2007 to 2016. CONCLUSION: Long-term exposure to ozone contributes to the COPD burden among the general population in Germany. As climate change may lead to a rise in the ozone concentration, more intensive research is required on the effects of ozone on health.
Authors: Meng Wang; Carrie Pistenmaa Aaron; Jaime Madrigano; Eric A Hoffman; Elsa Angelini; Jie Yang; Andrew Laine; Thomas M Vetterli; Patrick L Kinney; Paul D Sampson; Lianne E Sheppard; Adam A Szpiro; Sara D Adar; Kipruto Kirwa; Benjamin Smith; David J Lederer; Ana V Diez-Roux; Sverre Vedal; Joel D Kaufman; R Graham Barr Journal: JAMA Date: 2019-08-13 Impact factor: 56.272
Authors: Michelle C Turner; Michael Jerrett; C Arden Pope; Daniel Krewski; Susan M Gapstur; W Ryan Diver; Bernardo S Beckerman; Julian D Marshall; Jason Su; Daniel L Crouse; Richard T Burnett Journal: Am J Respir Crit Care Med Date: 2016-05-15 Impact factor: 21.405
Authors: Chris C Lim; Richard B Hayes; Jiyoung Ahn; Yongzhao Shao; Debra T Silverman; Rena R Jones; Cynthia Garcia; Michelle L Bell; George D Thurston Journal: Am J Respir Crit Care Med Date: 2019-10-15 Impact factor: 21.405
Authors: Ioana D Olaru; Steven Van Den Broucke; Andrew J Rosser; Helmut J F Salzer; Gerrit Woltmann; Emmanuel Bottieau; Christoph Lange Journal: Respiration Date: 2018-02-07 Impact factor: 3.580
Authors: Alexander Rommel; Elena von der Lippe; Dietrich Plass; Thomas Ziese; Michaela Diercke; Matthias An der Heiden; Sebastian Haller; Annelene Wengler Journal: Dtsch Arztebl Int Date: 2021-03-05 Impact factor: 5.594
Authors: A Fortems-Cheiney; G Foret; G Siour; R Vautard; S Szopa; G Dufour; A Colette; G Lacressonniere; M Beekmann Journal: Nat Commun Date: 2017-07-25 Impact factor: 14.919
Authors: Aaron J Cohen; Michael Brauer; Richard Burnett; H Ross Anderson; Joseph Frostad; Kara Estep; Kalpana Balakrishnan; Bert Brunekreef; Lalit Dandona; Rakhi Dandona; Valery Feigin; Greg Freedman; Bryan Hubbell; Amelia Jobling; Haidong Kan; Luke Knibbs; Yang Liu; Randall Martin; Lidia Morawska; C Arden Pope; Hwashin Shin; Kurt Straif; Gavin Shaddick; Matthew Thomas; Rita van Dingenen; Aaron van Donkelaar; Theo Vos; Christopher J L Murray; Mohammad H Forouzanfar Journal: Lancet Date: 2017-04-10 Impact factor: 79.321
Authors: Susan C Anenberg; Daven K Henze; Veronica Tinney; Patrick L Kinney; William Raich; Neal Fann; Chris S Malley; Henry Roman; Lok Lamsal; Bryan Duncan; Randall V Martin; Aaron van Donkelaar; Michael Brauer; Ruth Doherty; Jan Eiof Jonson; Yanko Davila; Kengo Sudo; Johan C I Kuylenstierna Journal: Environ Health Perspect Date: 2018-10 Impact factor: 9.031